Enterprise Value
1.561B
Cash
422.7M
Avg Qtr Burn
-43.3M
Short % of Float
10.70%
Insider Ownership
28.14%
Institutional Own.
54.81%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Navacaprant (NMRA-140) Details Major depressive disorder, Mental health Big Mover™ Suspected Mover™ Susp. Mover™ | Phase 3 Data readout | |
Navacaprant (NMRA-140) Details Mental health, Bipolar depression | Phase 2 Data readout | |
NMRA-511 Details Agitation in Alzheimer's Disease, Alzheimer's disease | Phase 1 Data readout | |
NMRA-266 Details Schizophrenia, Mental health | Phase 1 Update |